Home›People›Alaa Halawa
AH

Alaa Halawa

Director at Ollin Biosciences. Also a director at InnovAccer.

DirectorRoles at 2 startups
Updated Nov 10, 2026·Latest SEC filing Jun 24, 2026·Suggest an edit

About Alaa Halawa

Alaa Halawa is a director at Ollin Biosciences.

Form D filings also name Alaa Halawa as a director at InnovAccer.

Experience

This experience comes from Alaa Halawa's profile and from SEC filings. For roles taken from filings, the years are when the filings name Alaa Halawa in the role, so the role may have started earlier or lasted longer.

Ollin Biosciences, Inc. Current
Founding Investor and Board Member
2024 – Present · Austin, TX
Develops treatments for people with diseases that threaten their vision.
Salma Health Current
Cofounder and Chief Executive Officer
2024 – Present
Tenvie Therapeutics Current
Founding Investor and Board Member
2024 – Present
Metsera Current
Founding Investor
2023 – Present
Neumora Current
Board Member
2021 – Present
Pretzel Therapeutics Current
Founding Investor and Board Member
2021 – Present
InnovAccer Inc. Current
Director
2019 – Present · San Francisco, CA
Mubadala Current
Head of Healthcare (2017 – Present)
Vice President - Mubadala Technology (2009 – 2014)
2009 – Present
GLOBALFOUNDRIES
Director, Strategy & Corporate Development
2014 – 2015
Globitel
Director of Marketing and Product Management
2004 – 2009

Key Colleagues at Startups

The people Alaa Halawa works with at each company, as listed on that company's latest Form D.

Ollin Biosciences, Inc. · Form D, Jun 24, 2026
TM
FC
Fred Cohen
Director
CC
JE
Jason Ehrlich
Co-founder and Chief Executive Officer, director
PB
Paul Berns
Director
JC
Jason Coloma
Director
InnovAccer Inc. · Form D, Oct 29, 2025
WR
Wendy Rubas
Chief Legal and Compliance Officer
AS
Abhinav Shashank
Chief Executive Officer and Director
GS
Glenn Steele
Director
SC
Sumir Chadha
Director
SG
Sandeep Gupta
Chief Operations Officer and Director
SB
Scott Bruckner
Chief Financial Officer
AM
Ankit Maheshwari
Chief Technology Officer
KH
Kanav Hasija
Director

Sources

  1. SECOllin Biosciences, Inc. Form D, filed Jun 24, 2026
  2. SECInnovAccer Inc. Form D, filed Oct 29, 2025